Cronos (CRON) Research & Development (2019 - 2026)
Cronos' (CRON) quarterly Research & Development came in at $1.4 million in Q1 2026, up 78.18% year-on-year from $793000.0 in Q1 2025, and up 2.24% quarter-over-quarter from $1.4 million in Q4 2025.
Cronos (CRON) Research & Development (2019 - 2026) Analysis & Trends
Cronos' Research & Development history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- On a quarterly basis, Research & Development rose 78.18% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 64.86% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 79.41% from the prior year.
- Research & Development advanced to $1.4 million in Q1 2026 per CRON's latest filing, from $1.4 million in the prior quarter.
- Across five years, Research & Development topped out at $18.4 million in Q4 2024 and bottomed at -$10.5 million in Q4 2023.
- The 5-year median for Research & Development is $4.2 million (2022), against an average of $3.4 million.
- Across the five-year window, Research & Development plunged 287.21% in 2023 and jumped 343.66% in 2024, its largest moves.
- Year by year, Research & Development stood at $5.6 million in 2022, then plunged by 287.21% to -$10.5 million in 2023, then jumped by 275.41% to $18.4 million in 2024, then plunged by 92.49% to $1.4 million in 2025, then grew by 2.24% to $1.4 million in 2026.
- Per Business Quant, the three latest CRON Research & Development figures stand at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 138.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 929,000.00 |
| Mar 31, 2025 | 793,000.00 |
| Dec 31, 2024 | 18.40 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Jun 30, 2024 | 962,000.00 |
| Mar 31, 2024 | 997,000.00 |
| Dec 31, 2023 | -10.49 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 5.74 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 5.25 Mn |
| Jun 30, 2022 | 4.19 Mn |
| Mar 31, 2022 | 5.01 Mn |
| Dec 31, 2021 | 5.07 Mn |
| Sep 30, 2021 | 6.47 Mn |
| Jun 30, 2021 | 13.21 Mn |